Cannabis rescheduling plans spark concerns among GOP senators
Seeking Alpha News (Wed, 27-Mar 12:42 PM ET)
TipRanks (Tue, 26-Mar 8:10 AM ET)
Cronos Launches Lord Jones Chocolate Fusions
Globe Newswire (Mon, 25-Mar 7:00 AM ET)
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Benzinga (Mon, 25-Mar 5:34 AM ET)
Germany cannabis legalization on schedule as bill clears final hurdle
Seeking Alpha News (Sat, 23-Mar 2:11 PM ET)
Cronos Group Inc. to Speak at the 36th Annual Roth Conference
Globe Newswire (Tue, 12-Mar 4:15 PM ET)
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results
Globe Newswire (Thu, 29-Feb 8:05 AM ET)
Globe Newswire (Wed, 14-Feb 4:15 PM ET)
Cronos' Spinach Brand Ends 2023 as the Number One Flower Brand in Canada1
Globe Newswire (Thu, 25-Jan 7:00 AM ET)
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
Globe Newswire (Thu, 11-Jan 8:45 AM ET)
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
Cronos Group - Common Share trades on the NASDAQ stock market under the symbol CRON.
As of March 28, 2024, CRON stock price climbed to $2.71 with 1,256,162 million shares trading.
CRON has a beta of 0.91, meaning it tends to be less sensitive to market movements. CRON has a correlation of 0.04 to the broad based SPY ETF.
CRON has a market cap of $1.03 billion. This is considered a Small Cap stock.
Last quarter Cronos Group - Common Share reported $24 million in Revenue and -$.05 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.04.
In the last 3 years, CRON stock traded as high as $9.87 and as low as $1.64.
The top ETF exchange traded funds that CRON belongs to (by Net Assets): YOLO, DISV, DFIC, DFAX, DFIS.
CRON has outperformed the market in the last year with a price return of +38.3% while the SPY ETF gained +33.7%. CRON has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +33.5% and +34.2%, respectively, while the SPY returned +10.2% and +1.7%, respectively.
CRON support price is $2.60 and resistance is $2.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CRON stock will trade within this expected range on the day.